Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

Dassault Systèmes and the FDA Extend Collaboration to Inform Cardiovascular Device Review Process and Accelerate Access to New Treatments

July 24, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

June 19, 2019

News Industry News

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

June 04, 2019

News Industry News

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

May 14, 2019

News Industry News

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

May 09, 2019

News Industry News

Intelligent Data Analytics Software Solution Comes To Electrophysiology With Launch Of Biosense Webster’s Cartonet

May 07, 2019

News Industry News

First-of-its-Kind Large Access Dilator Launches in U.S., Following Cleveland Clinic Case

May 02, 2019

News Industry News

Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias

April 30, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

April 18, 2019

News Industry News

Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases

February 26, 2019

News Industry News

First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter

February 04, 2019

News Industry News

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

January 22, 2019

Advertisement

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Dassault Systèmes and the FDA Extend Collaboration to Inform Cardiovascular Device Review Process and Accelerate Access to New Treatments

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

Intelligent Data Analytics Software Solution Comes To Electrophysiology With Launch Of Biosense Webster’s Cartonet

First-of-its-Kind Large Access Dilator Launches in U.S., Following Cleveland Clinic Case

Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases

First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content